Hossein Jadvar, MD
Nuclear Medicine · Los Angeles, CANPI 1528009941
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $210,029 of the $294,482 with a category attached, or 71.3%. Progenics Pharmaceuticals, Inc. accounts for 66.7% of it on its own, with 8 other manufacturers making up the rest. Among nuclear medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $1015.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Progenics Pharmaceuticals, Inc.$196K
- Blue Earth Diagnostics$54K
- Siemens Medical Solutions USA, Inc.$13K
- Lantheus Medical Imaging, Inc.$11K
- Bayer Healthcare LLC$10K
- AbbVie$6K
- plus $5K from 3 others
What the payments were for
- Consulting fees$22,1118%
- Speaking & faculty fees$210,02971%
- Travel & lodging$56,02819%
- Food & beverage$6,3142%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Progenics Pharmaceuticals, Inc. | 183 | $196,464 |
| Blue Earth Diagnostics | 62 | $53,606 |
| Siemens Medical Solutions USA, Inc. | 6 | $12,573 |
| Lantheus Medical Imaging, Inc. | 7 | $11,050 |
| Bayer Healthcare LLC | 10 | $9,691 |
| AbbVie | 7 | $5,939 |
| Bayer | 12 | $4,121 |
| Telix Pharmaceuticals | 2 | $754 |
| United Imaging Healthcare North America, Inc. | 1 | $285 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$294,482 in reported general payments places this provider in the 95th percentile of 110 nuclear medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in Los Angeles
- Johannes CzerninLos Angeles$24K
- Gholam BerenjiLos Angeles$15K
- Shahram BonyadlouLos Angeles$12K
- Daniel SilvermanLos Angeles$8K
- Patrick CollettiLos Angeles$578
- Do KimLos Angeles$508
- David WinsorLos Angeles$136
- Shadfar BahriLos Angeles$80
- Louise ThomsonLos Angeles$31
- Michael DaeSan Francisco$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.